Neil Hattangadi Email & Phone

CEO @ Cortica | Advanced Neurological Therapies for Autism

Board Member @ Intersect ENT, Inc

Board Member @ Vesper Medical, Inc.

Executive Advisor @ Entellus Medical, Inc.

President and COO @ Spirox, Inc.

Executive Vice President and General Manager, Peripheral Vascular and Global Clinical Affairs @ Volcano Corporation

Senior Analyst, Healthcare Equities @ Surveyor Capital / Citadel Investment Group

Analyst, Healthcare Equities @ Sigma/SAC Capital

Vice President, Molecular Programs and FoxHollow Clinical Affairs @ ev3 Inc./ FoxHollow Technologies

Management Consultant @ McKinsey & Company

Research Associate @ Whitehead Genome Center/ Broad Institute

2001 - 2005 MD @ Harvard Medical School

1999 - 2001 MSc @ University of Oxford

1995 - 1999 BSE @ Duke University

Neil Hattangadi, based in San Diego, CA, US, is currently a CEO at Cortica | Advanced Neurological Therapies for Autism. Neil Hattangadi brings experience from previous roles at Intersect ENT, Inc, Vesper Medical, Inc., Entellus Medical, Inc., Spirox, Inc., Volcano Corporation, Surveyor Capital / Citadel Investment Group, Sigma/SAC Capital, ev3 Inc./ FoxHollow Technologies, McKinsey & Company, Whitehead Genome Center/ Broad Institute. Neil Hattangadi holds various educational qualifications including MD (2001 - 2005) from Harvard Medical School. With a robust skill set that includes a diverse set of professional skills, Neil Hattangadi demonstrates proficiency in a wide range of areas.